Home » Headlines » Currently Reading:

Morning Headlines 6/6/16

June 5, 2016 Headlines No Comments

McKesson Considers Separation of Information-Technology Unit

McKesson may sell its health IT business unit to focus efforts on its core drug distribution business. The business unit is valued at an estimated $5 billion. 

Theranos CEO Elizabeth Holmes Did Not Just Lose $4.5 Billion

Fortune’s Dan Primack argues that Theranos CEO Elizabeth Holmes never should have been listed as a billionaire by Forbes because her worth was based entirely on her ownership stake in a company whose value was set by “a small group of outside investors.”

Pioneering Data-Sharing Network Created to Accelerate Cancer Precision Medicine Development

Intermountain Healthcare, Stanford Cancer Institute, and Providence Health & Services launch a data-sharing network that will transmit genomic data from cancer research to help oncologists develop more effective treatment plans.

Potential Patient Information Breach at ProMedica Bixby and Herrick Hospitals

ProMedica Bixby and Herrick hospitals (MI) informs 3,500 patients that their records were breached after an internal investigation found that seven employees were accessing patient records without justification.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Merry Christmas and a Happy New Year to the HIStalk crowd. I wish you the joys of the season!

  2. "most people just go to Epic" that's a problem because then EPIC becomes a monopoly in healthcare, if it isn't…

  3. Only if CEO can post 'bail' which nowadays stands at 1B$ paid directly to the orange president or his family…

  4. I enjoy reading about the donations to Donor's Choice by HIStalk members. I also believe in the worthiness of Donor's…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.